GovWire

Form: Rabies post exposure risk assessment form and calendar

Public Health England

April 8
08:46 2021

Rabies post exposure risk assessment form and calendar

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email publications@phe.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The current lot of human rabies immunoglobulin (HRIG) in use in England is JRC20309A. The potency is 362 IU/ml, vial volume is 2.0 ml, and the expiry date is 31 August 2022.

Return completed risk assessment form to the vaccine clerk, Rabies and Immunoglobulin Service by email to RIGS@phe.gov.uk or PHE.RIGS@nhs.net.

Published 31 December 2013
Last updated 8 April 2021 +show all updates
  1. Added updated risk assessment form with version 35.

  2. Added updated risk assessment form v34.

  3. Added updated risk assessment form v33.

  4. Updated with form version 32.

  5. Added updated risk assessment form (v31).

  6. Added updated risk assessment form and updated the details of the current HRIG in use.

  7. Added new telephone number for the Rabies and Immunoglobulin service.

  8. Updated with form version 29.

  9. Updated with version 28, and details of the new batch of rabies immunoglobulin in use from 1 May 2019.

  10. Updated with form version 27.

  11. Updated with form version 26.

  12. Updated with form version 25.

  13. Updated with form version 24.

  14. Updated with form version 23.

  15. Updated with form version 22.

  16. Updated with form version 21.

  17. Updated to reflect new guidance and current vaccines and HRIG in use.

  18. Update

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: